Targeting Cancer-Specific Mutations with RNA-Triggered Chromatin Shredding - Nature
Researchers have developed a new method using CRISPR-Cas12a2 to target cancer-specific mutations by shredding chromatin. This approach allows for the precise destruction of cancer cells that were previously considered undruggable.
Why it matters
This represents a significant breakthrough in precision oncology, potentially offering new treatment pathways for difficult-to-treat cancers.
We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.
Scientific reporting based on peer-reviewed research findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in